Evidence from historical US conflicts makes it clear that early administration of antibiotics in the field improves outcomes for battlefield casualties. Safety profiles are good for field antibiotics used in US combat medicine, and adverse reactions are rare. Currently, moxifloxacin (4th generation flouroquinolone) is the US military oral antibiotic of choice. Ertapenem (a carbapenem) is the parenteral antibiotic of choice. Together, these drugs cover a wide spectrum of potential infectious microbes.
The US Combat Wound Medication Pack contains 400mg moxifloxacin, along with 15mg meloxicam and 500mg acetominophen. The Ukrainian medication pack contains a similar assemblage of pills.
No comments:
Post a Comment